NCT04890002

Brief Summary

The aim of this study is to explore the effects of a far-infrared emitting pyjamas on improving sleep in adults with poor sleep.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 18, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 15, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

May 12, 2021

Last Update Submit

September 21, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pittsburgh Sleep Quality Index (PSQI)

    The PSQI is a self-reported evaluation of the overall sleep quality. Subjects will be asked to report the sleep parameters of their sleep problem, use of sleep medicine, disturbance, and daytime dysfunction with 0-3 rating. The time frame of PSQI adopted in this study will be changed from "past 1 month" to "past 2 weeks". The PSQI is a reliable and validated tool widely used in sleep studies.

    Baseline, week 2, week 4, and week 6

Secondary Outcomes (6)

  • Insomnia Severity Index (ISI)

    Baseline, week 2, week 4, and week 6

  • The 7-day daily sleep diary

    Baseline and week 6

  • Hospital Anxiety and Depression Scale (HADS)

    Baseline, week 2, week 4, and week 6

  • Epworth Sleepiness Scale (ESS)

    Baseline, week 2, week 4, and week 6

  • The 5-item Satisfaction with Life Scale (SWLS)

    Baseline, week 2, week 4, and week 6

  • +1 more secondary outcomes

Study Arms (2)

Far-infrared emitting pyjamas (FIR pyjamas) group

EXPERIMENTAL

Subjects in this group will be provided the Far-infrared emitting pyjamas. The FIR pyjamas was fabricated by using two textile materials, pure cotton fibres and the proposed man-made FIR fibres with the far-infrared emitting function.

Device: Far-infrared emitting pyjamas

Sham-pyjamas Group

SHAM COMPARATOR

To control the placebo effect in the FIR pyjamas group, participants in this group will receive pyjamas with identical physical appearance which are produced using the same fabrication process as the pyjamas received in FIR pyjamas group. The sham-pyjamas are made of pure cotton fibres and man-made fibres without the far-infrared emitting function. The participants will be asked to wear the sham-pyjamas daily at night for 6 consecutive weeks.

Device: Sham-pyjamas

Interventions

Clothing made in far infrared (FIR) - based textiles could be a sustainable way for alleviating sleep problems with many advantages. Firstly, the proposed far infrared textiles are made of man-made profiled fibers without the addition of chemicals such as ceramic additives or other related coatings.

Far-infrared emitting pyjamas (FIR pyjamas) group

The sham-pyjamas are made of pure cotton fibres and man-made fibres without the far-infrared emitting function.

Sham-pyjamas Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chinese Hong Kong residents who are able to read Chinese;
  • Aged 18 - 65 years;
  • Subjective sleep complaints of having difficulties in falling asleep, difficulties in staying asleep, or early morning awakening with consequences for daily life for at least 3 months.
  • Pittsburgh Sleep Quality Index total score of at least 5 indicating sleep disturbance with 89.6% sensitivity and 86.5% specificity; and
  • Willing to give informed consent and comply with the trial protocol.

You may not qualify if:

  • Currently receiving psychotherapy or participating in other clinical trials for insomnia;
  • Pregnancy;
  • Shift workers;
  • At significant suicidal risk as rated by the Hamilton Depression Rating Scale item on suicide (score ≥ 3);
  • No comorbid sleep disorders primarily requiring other treatment, such as sleep apnea or narcolepsy; and
  • Taking herbal remedies, over-the-counter medication, or psychotropic drugs that target insomnia within the 2 weeks prior to baseline.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wing Fai YEUNG

Hong Kong, 000000, Hong Kong

Location

MeSH Terms

Conditions

Sleep Wake Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • Wing Fai YEUNG, Dortor

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

May 12, 2021

First Posted

May 18, 2021

Study Start

July 15, 2021

Primary Completion

December 31, 2021

Study Completion

March 31, 2022

Last Updated

September 25, 2023

Record last verified: 2023-09

Locations